C07D 211/10
With radicals containing only carbon and hydrogen atoms attached to ring carbon
Official title: with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
C07D211/10 (With radicals containing only carbon and hydrogen atoms attached to ring carbon) appears on 1,042 US grants and 929 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,042
- Published applications
- 929
- Assignees
- 567
- Inventors
- 3,400
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 17 | 0 |
| 1977 | 31 | 0 |
| 1978 | 37 | 0 |
| 1979 | 17 | 0 |
| 1980 | 13 | 0 |
| 1981 | 13 | 0 |
| 1982 | 13 | 0 |
| 1983 | 15 | 0 |
| 1984 | 4 | 0 |
| 1985 | 14 | 0 |
| 1986 | 9 | 0 |
| 1987 | 9 | 0 |
| 1988 | 6 | 0 |
| 1989 | 10 | 0 |
| 1990 | 14 | 0 |
| 1991 | 12 | 0 |
| 1992 | 17 | 0 |
| 1993 | 16 | 0 |
| 1994 | 14 | 0 |
| 1995 | 8 | 0 |
| 1996 | 8 | 0 |
| 1997 | 40 | 0 |
| 1998 | 12 | 0 |
| 1999 | 13 | 0 |
| 2000 | 18 | 0 |
| 2001 | 24 | 3 |
| 2002 | 26 | 20 |
| 2003 | 19 | 35 |
| 2004 | 15 | 46 |
| 2005 | 22 | 46 |
| 2006 | 18 | 37 |
| 2007 | 15 | 40 |
| 2008 | 24 | 32 |
| 2009 | 34 | 32 |
| 2010 | 23 | 49 |
| 2011 | 23 | 36 |
| 2012 | 22 | 35 |
| 2013 | 32 | 36 |
| 2014 | 40 | 34 |
| 2015 | 37 | 60 |
| 2016 | 42 | 52 |
| 2017 | 33 | 37 |
| 2018 | 36 | 42 |
| 2019 | 33 | 31 |
| 2020 | 30 | 33 |
| 2021 | 24 | 36 |
| 2022 | 20 | 33 |
| 2023 | 14 | 28 |
| 2024 | 21 | 34 |
| 2025 | 21 | 47 |
| 2026 | 14 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical29 Sep 2026US 12,746,202 B2National University Corporation Chiba University
- Substituted diaryl compound as well as preparation method and application thereof29 Sep 2026US 12,747,209 B2Shandong First Medical. Univ & Shandong Academy of Medical Sciences
- Acid addition salts of (s)-3-(2,5-dimethoxy-4-(trifluoromethyl)phenyl)piperidine and (s)-3-(2-methoxy-5-(methylthio)-4-(trifluoromethyl)phenyl)piperidine, specific polymorphs thereof and methods for their manufacture1 Sep 2026US 12,723,024 B2Lophora ApS
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- TRPML modulators4 Aug 2026US 12,698,266 B2Casma Therapeutics, Inc.
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
- Bulky and small-steric-hindrance ligand and use thereof17 Sep 2026US 2026/0273518 A1Dg Hc Optical Co., Ltd
- Catalyst for sp3-carbon-hydrogen-bond primary amination reaction, and method for preparing primary amine compound13 Aug 2026US 2026/0234096 A1West China Second University Hospital, Sichuan University
- Erap1 modulating compounds16 Jul 2026US 2026/0199455 A1Grey Wolf Therapeutics Limited
- Ionizable lipids and compositions and uses thereof2 Jul 2026US 2026/0184671 A1Massachusetts Institute of Technology
Most cited
By later US patents
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- Intermediates of peripherally selective N-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists116US 5,159,081 AEli Lilly and Company · 1992
- Peripherally selective piperidine opioid antagonists86US 5,270,328 AEli Lilly and Company · 1993
- Selective estrogen receptor modulator79US 7,612,114 B2Eisai R&D Management Co., Ltd. · 2009